Validation of Posttraumatic Stress Disorder (PTSD) and Complex-PTSD using the International Trauma Questionnaire by Hyland, Philip et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/102266/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Hyland, Philip, Shevlin, Mark, Brewin, Chris R., Cloitre, Marylene, Downes, Anthony, Jumbe,
Sandra, Karatzias, Thanos, Bisson, Jonathan Ian and Roberts, Neil 2017. Validation of
Posttraumatic Stress Disorder (PTSD) and Complex-PTSD using the International Trauma
Questionnaire. Acta Psychiatrica Scandinavica 136 (3) , pp. 313-322. 10.1111/acps.12771 file 
Publishers page: http://dx.doi.org/10.1111/acps.12771 <http://dx.doi.org/10.1111/acps.12771>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
RUNNING TITLE: Validity of ICD-11 PTSD and CPTSD 
 1 
Validation of Posttraumatic Stress Disorder (PTSD) and Complex-PTSD using the 
International Trauma Questionnaire 
Authors 
Philip Hyland, National College of Ireland, Dublin, Ireland, and Centre for Global Health, 
Trinity College Dublin, Dublin, Ireland. Philip.hyland@ncirl.ie  
Mark Shevlin, Ulster University, School of Psychology, Derry, Northern Ireland. 
M.shevlin@ulster.ac.uk  
Chris R. Brewin, University College London, Clinical Educational & Health Psychology, 
London, UK. C.brewin@ucl.ac.uk  
Marylene Cloitre, New York University, School of Medicine, USA, and, National Center for 
PTSD, Veterans Affairs Palo Alto Health Care System, Palo Alto, USA. 
Marylene.cloitre@va.govnyumc.org 
Anthony J. Downes, Betsi Cadwaldr Health Board, St Mark’s Dee View Surgery, Connah’s 
Quay, UK. Tony.Downes@wales.nhs.uk  
Sandra Jumbe, Queen Mary University of London, Research Design Service London, Centre 
for Primary Care and Public Health, London, UK. s.jumbe@qmul.ac.uk  
Thanos Karatzias, Edinburgh Napier University, School of Health & Social Care, UK, and 
NHS Lothian, Rivers Centre for Traumatic Stress, Edinburgh, UK. t.karatzias@napier.ac.uk  
*Jonathan I. Bisson, Cardiff University, School of Medicine, Cardiff, UK. 
BissonJI@cardiff.ac.uk  
*Neil P. Roberts, Psychology and Counselling Directorate, Cardiff & Vale University Health 
Board, Cardiff, UK. RobertsNP1@cardiff.ac.uk  
* Jonathan I. Bisson and Neil P. Roberts are joint senior authors. 
 
Corresponding Author: Philip Hyland 
 
 
 
 
 
 
 
 
 
 
RUNNING TITLE: Validity of ICD-11 PTSD and CPTSD 
 2 
Abstract 
Objective: The 11th version of the International Classification of Diseases (ICD-11) has 
proposed two related trauma diagnoses: Posttraumatic Stress Disorder (PTSD) and Complex 
PTSD (CPTSD). Using a newly developed, disorder-specific measure of PTSD and CPTSD 
called the International Trauma Questionnaire (ITQ) the current study will: (1) assess the 
factorial validity of ICD-11 PTSD and CPTSD; (2) provide the first test of the discriminant 
validity of these constructs; and (3) provide the first comparison of ICD-11, and Diagnostic 
and Statistical Manual, Fifth Edition (DSM-5), PTSD diagnostic rates using disorder-specific 
measures. 
Method: ICD-11 and DSM-5 PTSD specific measures were completed by a British clinical 
sample of trauma-exposed patients (N = 171). The structure and validity of ICD-11 PTSD 
and CPTSD were assessed by means of factor analysis and assessing relationships with 
criterion variables.     
Results: Diagnostic rates under ICD-11 were significantly lower than those under DSM-5. A 
two-factor second-order model reflecting the distinction between PTSD and CPTSD best 
represented the data from the ITQ; and the PTSD and CPTSD factors differentially predicted 
multiple psychological variables. 
Conclusion: The factorial and discriminant validity of ICD-11 PTSD and CPTSD was 
supported, and ICD-11 produces fewer diagnostic cases than DSM-5. 
Declaration of interest: Chris Brewin and Marylène Cloitre participated as members of the 
World Health Organization Working Group on the Classification of Disorders Specifically 
Associated with Stress, reporting to the International Advisory Group for the Revision of 
ICD-10 Mental and Behavioural Disorders. However, the views expressed reflect the 
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opinions of the authors and not necessarily the Working Group or Advisory Group and the 
content of this article does not represent WHO policy. 
Marylene Cloitre, Neil Roberts, Jonathan Bisson, and Chris Brewin are co-authors of the 
ITQ. 
Philip Hyland, Mark Shevlin, Anthony J. Downes, Sandra Jumbe, Thanos Karatzias have no 
conflicts of interest. 
Key words: posttraumatic stress disorder (PTSD); complex posttraumatic stress disorder 
(CPTSD); ICD-11; DSM-5; stress-related disorders; anxiety and depression. 
Significant outcomes: 
 Diagnostic rates of ICD-11 PTSD and CPTSD are significantly lower than DSM-5 
PTSD. 
 The factorial validity of ICD-11 PTSD and CPTSD was supported using the newly 
developed International Trauma Questionnaire. 
 The discriminant validity of ICD-11 PTSD and CPTSD was evidenced for the first 
time. 
Limitations: 
 The current study was based on a relatively small clinical sample, limiting 
generalizability of findings. 
 Diagnostic rates for ICD-11 and DSM-5 were estimated without a measure of 
functional impairment. 
 The ITQ is still under development and will be reduced in length in the near future to 
simplify the calculations required to meet the ICD-11 diagnoses for PTSD and 
CPTSD. 
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Introduction 
The forthcoming International Classification of Diseases version 11 (ICD-11) will 
include a diagnosis of Posttraumatic Stress Disorder (PTSD) comprised of six symptoms 
reflecting three factors: (i) Re-experiencing in the here and now (Re: two symptoms), (ii) 
deliberate avoidance (Av: two symptoms), and (iii) a sense of current threat (Th: two 
symptoms) (1). A sibling diagnosis, Complex PTSD (CPTSD), will also be included in ICD-
11 and will be comprised of the six PTSD symptoms plus an additional set of symptoms that 
reflect ‘Disturbances in Self-Organization’ (DSO). These DSO symptoms are intended to 
capture the pervasive psychological disturbances that can occur following exposure to 
trauma, particularly those of an interpersonal nature that occur in early development, that are 
of a repeated and prolonged nature, and from which escape is difficult or impossible. The 
ICD-11 Working Group for Disorders Specifically Associated with Stress have not yet 
finalised the number of DSO symptoms that will be included in ICD-11, however the DSO 
symptoms will comprise three factors: (i) Affective Dysregulation (AD), (ii) Negative Self-
Concept (NSC), and (iii) Disturbed Relationships (DR) (1). Given their symptom 
composition, PTSD is conceptualised as a fear-based disorder, whereas CPTSD is 
conceptualised a broader clinical disorder that characterizes the impact of trauma on emotion 
regulation, identity and interpersonal domains 
Several studies have sought to compare diagnostic rates of ICD-11 PTSD and CPTSD 
to DSM-5 PTSD. Findings have suggested a general trend for the ICD-11 to generate 
significantly lower diagnostic rates compared to the DSM-5 (2-4). In addition, considerable 
support for the factorial validity of ICD-11 PTSD (2-5) and CPTSD (6-9) has accrued. These 
studies are limited however as each relied on the use of proxy variables derived from 
secondary data sources to capture the ICD-11 PTSD and DSO symptoms. In order to have a 
standardised assessment of these symptoms which aligns with the ICD-11 diagnostic criteria, 
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the International Trauma Questionnaire (ITQ) (10) was developed. An initial confirmatory 
factor analytic (CFA) study amongst a clinical sample indicated that the latent structure of the 
ITQ was consistent with the proposed two-factor second-order model of CPTSD (i.e., a 
conceptual model that distinguishes between PTSD and CPTSD symptoms) (11). 
Additionally, mixture-modelling studies have supported the presence of distinct classes of 
trauma survivors characterised by PTSD and CPTSD symptom profiles (12,13). 
Aims of the study 
Given the recent development of the ITQ, and the limited number of studies which 
have tested the validity of the PTSD and CPTSD proposals using this measure, the current 
study was performed to address two primary goals. First, we sought to determine whether the 
factor structure of the ITQ reported by Karatzias et al. (11) could be replicated amongst a 
distinct clinical sample (factorial validity). Second, we sought to extend upon existing 
knowledge by (a) performing the first comparison of ICD-11 PTSD/CPTSD diagnostic rates 
and DSM-5 PTSD diagnostic rates using disorder-specific measures (the ITQ and the PCL-5 
(14)); and (b) to provide the first assessment of the discriminant validity of ICD-11 PTSD 
and CPTSD. Three hypotheses were formulated in line with theoretical proposals and 
previous empirical findings. First, based on existing data (2-4), it was hypothesised that fewer 
people would meet diagnostic status under ICD-11 (PTSD and CPTSD) than DSM-5 (PTSD). 
Second, in line with theoretical proposals (1) and empirical findings (11), it was hypothesised 
that factorial models of the ITQ which discriminate between PTSD and DSO symptoms 
would offer optimal model fit. Third, consistent with the distinct symptom compositions of 
ICD-11 PTSD (fear/anxiety based symptoms elicited by trauma-related cues) and CPTSD 
(emotional regulatory, self-conceptual, and interpersonal symptoms which are pervasive and 
not bound to trauma-related stimuli), it was hypothesised that the disorders would be 
differentially associated with six criterion variables. Specifically, it was hypothesised that the 
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PTSD factor(s) would be stronger predictors of panic disorder (PD) and generalized anxiety 
disorder (GAD) symptoms than the CPTSD factor(s); and the CPTSD factor(s) would be 
stronger predictors of symptoms of Major Depressive Disorder (MDD), negative trauma-
cognitions, and distress tolerance than the PTSD factor(s).     
Methods 
Participants and Procedures 
Participants (n = 171; 51.5% male) were recruited via the National Centre for Mental 
Health (http://www.ncmh.info/). Participants were mental health service users who were 
recruited to NCMH via primary and secondary mental health services, specialist veteran’s 
services, a specialist civilian trauma service, and via social media. Participants were eligible 
for the study if they were aged 18 or older and they reported that they had previously been 
given a diagnosis of PTSD, or if they indicated exposure to a traumatic event and screened 
positively for PTSD on the basis of the Trauma Screening Questionnaire. Exclusion criteria 
included inability read and write in English or disturbed mental state, requiring recent 
admission to hospital or intensive home treatment. All participants reported exposure to a 
traumatic event fulfilling the gateway criterion for a diagnosis of PTSD and CPTSD under 
ICD-11 and DSM-5. Participants ranged in age from 18 to 78 years (M = 49.85, SD = 12.73), 
were primarily Caucasian (n = 162, 95.9%), and unemployed (n = 113, 66.9%). Most were 
married or co-habiting (n = 84, 49.7%), while the remainder were single (n = 35, 20.7%), 
divorced/separated (n = 43, 25.5%), or widowed (n = 7, 4.1%). A small proportion did not 
finish school (n = 12, 7.1%), and many had attended higher education (n = 80, 47.6%). This 
study received ethical approval from the United Kingdom’s National Research Ethics 
Service. 
Measures 
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Traumatic exposure: A modified version of the Life Events Checklist for DSM-5 
(LEC-5) (15) was used to assess lifetime exposure to traumatic events (with two additional 
items that assessed exposure to childhood physical abuse, and childhood sexual abuse or 
molestation). Individuals were deemed to have been exposed to a trauma if they reported that 
an event ‘Happened to me’ or ‘Witnessed it happening to somebody else’. A summed total 
score of types of trauma exposure was computed with a range of possible scores from 0-19. 
ICD-11 PTSD and DSO symptoms: The International Trauma Questionnaire (ITQ, 
version 1.2) (10) is a preliminary-stage self-report measure of the ICD-11 diagnoses of PTSD 
and CPTSD. This version of the scale contains a larger pool of items than will be included in 
the final version which will correspond to the ICD-11 diagnostic rules when finalised by the 
World Health Organization. Six items measure three PTSD clusters: (i) Re-experiencing in 
the here and now (Re1, Re2); deliberate avoidance of traumatic reminders (internal or 
external) (Av1, Av2); and a sense of current threat (Th1, Th2). A third Re item (Re3: Feeling 
very upset when something reminded you of the experience) was also included. Although it is 
non-specific in the sense that it does not address the ICD-11 concept of re-experiencing in the 
here and now, it is currently under consideration for use with traumatised individuals who 
possess no clear memory of their index trauma (e.g., possibly due to childhood traumatization 
or traumatic brain injuries)a. Sixteen items measure the three DSO factors: (i) Affective 
dysregulation, both hyper-activation (AD1-AD5) and hypo-activation (AD6-AD9); (ii) 
negative self-concept (NSC1-NCS4); and (iii) disturbances in relationships (DR1-DR3).  
Respondents are instructed to answer the PTSD question in relation to how much they 
have been bothered by each symptom in the past month; and are instructed to answer the 
DSO items in relation to how they typically feel, think about themselves, and relate to others. 
                                                          
a
  Please note that Re3 is currently considered as a test item for diagnostic purposes and thus will not be 
included in any of the modelling analyses in this study. 
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All items are answered on a five-point Likert scale anchored by ‘Not at all’ (0) and 
‘Extremely’ (4). Diagnostic criteria for PTSD requires a score of ≥ 2 (‘Moderately’) for at 
least one of two symptoms from the Re, Av, and Th clusters. CPTSD diagnosis requires that 
the PTSD criteria are met and endorsement of each DSO symptom cluster at a moderate level 
of severity, defined as summed score that equals a score of > 2 for each of the items in the 
cluster): a summed total score of ≥ 10 for items AD1-AD5 (reflecting hyper-activation) or a 
summed total score of ≥ 8 for items AD6-AD9 (reflecting hypo-activation); a summed total 
score ≥ 8 for items NSC1-NSC4; and a summed total score ≥ 6 for items DR1-DR3. The 
ICD-11 requires the presence of functional impairment associated with both sets of symptoms 
for a diagnosis of PTSD and CPTSD. However, functional impairment was not assessed in 
the current study, therefore diagnostic rates are based on symptom criteria alone. The ICD-
11’s taxonomic structure means that an individual can only be diagnosed with PTSD or 
CPTSD, not both.    
DSM-5 PTSD symptoms: The PTSD Checklist for DSM-5 (PCL-5) (14) is a 20-item, 
self-report measure of intrusions (I: 5 items), avoidance (Av: 2 items), negative alterations in 
cognition and mood (NACM: 7 items), and alterations in arousal and reactivity (Ar: 6 items). 
The PCL-5 uses the same Likert-scale response format as the ICD-TQ, and respondents 
answer each question in relation to how much they have been bothered by a symptom in the 
past month. PTSD diagnosis can be made if an individual reports a score of ≥ 2 for at least 
one I symptom, at least one Av symptom, at least two NACM symptoms, and at least two Ar 
symptoms. As with ICD-11, DSM-5 requires endorsement of functional impairment for 
diagnosis, however this was not assessed. Diagnostic rates are thus based on symptom criteria 
alone. Studies have reported acceptable psychometric properties for the PCL-5 (16). 
Reliability estimates among the current sample were satisfactory: I (α = .90), Av (α = .87), 
NACM (α = .84), Ar (α = .78).  
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Criterion variables 
 The GAD-7 (17) is a seven-item measure of DSM-IV GAD. Respondents indicate 
how much they are bothered by each symptom over the past two weeks. Each item is scored 
on a three-point Likert scale (1 = “not at all”, 3 = “more than half the days”). The GAD-7 has 
demonstrated good psychometric properties among clinical samples (18), and the reliability 
of the scale among the current sample was satisfactory (α = .86). 
 The PHQ-9 (19) is a nine-item measure of DSM-IV major depressive disorder. 
Respondents indicate how much they are bothered by each symptom over the past two weeks 
on a four-point Likert scale (0 = “not at all”, 3 = “nearly every day”). The PHQ-9 possesses 
satisfactory psychometric properties (20), and the reliability among the current sample was 
acceptable (α = .89).   
The PHQ-Panic Disorder (PHQ-PD) (21) is a 15-item measure of PD derived from 
the DSM-IV criteria. The first four questions (3a-3d) screen for whether a person has 
experienced an anxiety attack in the past four weeks. The remaining 11 questions (4a-4k) 
measure somatic (e.g., heart palpitation) and psychological (e.g., afraid of dying) symptoms. 
Each symptom is answered on a ‘yes’ (1) or ‘no’ (0) basis. A summed total score of panic 
symptoms is based on responses to the 11 symptomatic questions. PHQ-PD scores possess 
satisfactory psychometric properties (21) and the reliability amongst the current sample was 
good (α = .91).   
The Posttraumatic Cognitions Inventory (PTCI) (22) contains 33 self-report items 
which measure negative beliefs about the self (‘Self’: 21 items), the world (‘World’: 7 items), 
and self-blame (5 items). For the current study, the Self and World subscales were selected. 
Items are scored on a seven-point Likert scale (1 = ‘totally disagree’, 7 = ‘totally agree’) and 
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higher scores reflect increasingly negative beliefs. The reliability of the Self (α = .95) and 
World (α = .90) subscales were good.  
The Distress Tolerance Scale (23) is a 16-item self-report measure of one’s ability to 
regulate emotions, accept distressing emotions, and function effectively when distressed. 
Items are scored on a five-point Likert scale (1 = ‘strongly disagree’, 5 = ‘strongly agree’) 
and higher scores reflect higher levels of distress tolerance. The scale possesses good 
psychometric properties (24) and the internal reliability among the current sample was 
satisfactory (α = .87).  
Data analysis 
Combined ICD-11 PTSD and CPTSD diagnostic rates were compared to DSM-5 
PTSD diagnostic rates using the z-test. Diagnostic agreement between the two systems was 
assessed using Cohen’s kappa statistic where a value > .61 indicates acceptable agreement 
(25). The fit of seven alternative factor models of the ITQ, as outlined by Shevlin et al. (9) 
and Karatzias et al. (11) (see Figure 1), were investigated using CFA in Mplus 7.4 (26). The 
mean and variance-adjusted weighted least squares (WLSMV) estimator was used as it 
provides accurate parameter estimates, standard errors, and test-statistics for ordinal 
indicators (27). Missing data were managed using the pairwise present analysis method. 
Acceptable model fit was indicated by a chi-square-to-degree of freedom ratio of less than 
3:1 (28); CFI and TLI values > .90 indicate adequate fit and values > .95 indicate excellent fit 
(29); and RMSEA values < .08 indicate adequate fit and values < .06 indicate excellent fit 
(30). The WLSMV estimator does not produce information-based indices thus the models 
were also fitted using robust maximum likelihood (MLR) (31) estimation to generate the 
Bayesian Information Criterion (BIC). The BIC is used to compare nested and non-nested 
models and the model with the smaller value is deemed to be a better-fitting model. A 6- to 
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10-point difference between two models indicates strong evidence that the model with the 
lower value is statistically superior (32). 
FIGURE 1 
Upon selection of the best fitting model, composite reliability analysis was performed 
to determine the internal reliability of the ITQ. Composite reliability calculates internal 
consistency without the assumption of tau-equivalence and thus is more appropriate for 
measures with small numbers of items, such as the ITQ. Values > .60 indicate acceptable 
internal reliability (33).  
 Finally, summed PTSD/DSO scores based on the best fitting model of the ITQ were 
entered into a hierarchical multiple regression model to predict six criterion variables. 
Gender, age, employment status (0 = employed, 1 = unemployed), and relationship status (0 
= in a relationship, 1 = not in a relationship) were entered at Step 1, and the PTSD and DSO 
variables were entered at Step 2. 
Results 
Descriptive statistics and diagnostic estimates 
 The mean number of types of traumatic life events experienced was 6.75 (Mdn = 6.00, 
SD = 3.84), and the most frequently experienced trauma was physical assault (n = 121, 
73.7%). The experience of physical and/or sexual abuse during childhood was common (n = 
79, 47.6%). The most distressing traumatic events identified were childhood sexual abuse or 
molestation (n = 26, 15.5%), and combat (n = 22, 13.1%). Most respondents indicated a clear 
memory of their index (worst) trauma (n = 144, 87.8%). Amongst those who did not, the 
most common events associated with no memory were childhood sexual abuse or molestation 
(35%, n = 7) and physical assault (20%, n = 4). 
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The probable diagnostic rate for ICD-11 PTSD and CPTSD was 64.5% (n = 107). 
Following the ICD-11’s guidelines that a person may only receive a diagnosis of PTSD or 
CPTSD, but not both, it was necessary to calculate diagnostic rates for each diagnosis 
separately. The probable PTSD diagnostic rate was 10.9% (n = 18), and the probable CPTSD 
diagnostic rate was 53.6% (n = 89). With the inclusion of Re3, the combined PTSD and 
CPTSD probable diagnostic rate increased to 71.7% (n = 119); with PTSD increasing to 
12.7% (n = 21), and CPTSD increasing to 59.0% (n = 98). Endorsement rates for each ITQ 
item, based on one’s diagnosis (PTSD or CPTSD), are displayed in Table 1. 
TABLE 1 
 The DSM-5 PTSD probable diagnostic rate was 76.1% (n = 124); a diagnostic rate 
significantly higher than the combined ICD-11 PTSD and CPTSD rate (76.1% v. 64.5%, z = 
2.30, SE = .05, p = .01). One hundred and three (of 163) participants shared an ICD-11 and 
DSM-5 diagnosis; 21 participants received a diagnosis under DSM-5 but did not receive a 
diagnosis under ICD-11; and one person received a diagnosis under ICD-11 but did not 
receive a diagnosis under DSM-5. This level of diagnostic agreement between the two 
systems was considered to be reasonably high (Kappa = .69, SE = .06, p < .001).  
The DSM-5 PTSD diagnostic rate was not significantly different from the combined 
ICD-11 PTSD and CPTSD rate when the non-specific Re3 symptom was included within the 
ICD-11 diagnostic algorithm (76.1% v. 71.7%, z = 0.97, SE = .05, p = .18).  
Factorial validity and composite reliability 
 Model fit statistics for the ITQ are presented in Table 2. Models 2, 3, and 4 offered 
the best representations of the factor structure of the ITQ. Inspection of the BIC results 
indicates that Model 4 offers the optimal representation of the sample data. Model 4, which is 
consistent with the ICD-11 proposals for PTSD and CPTSD, possessed a chi-square to degree 
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of freedom ratio of < 3:1 indicating acceptable model fit; CFI and TLI values of .95 
indicating excellent fit; however, the RMSEA value was above the criteria for acceptable 
model fit. Considering all indices together, Model 4 appears to offer a viable representation 
of the latent structure of the ITQ. 
TABLE 2  
The first- and second-order PTSD factor loadings were all positive, statistically 
significant (p < .001), and high (> .70). The first- and second-order DSO factor loadings were 
all positive, and statistically significant (p < .001). While most first order factor loadings 
were of a robust magnitude, two AD items (uncontrollable anger and reckless behaviour) 
possessed factor loadings < .60. Additionally, the standardized factor loading of AD on the 
second-order DSO factor was 1.00 indicating perfect reliability; a result that often occurs in 
the context of high levels of multicollinearity but is not outside the normal range of results 
(34) (see Table 3 for full results). The factor correlation between PTSD and DSO was high (r 
= .89, p < .001). 
TABLE 3  
Composite reliability findings, based on estimates derived from the CFA analysis, 
indicated that the ITQ possesses excellent internal reliability. The six first-order subscales 
demonstrated high levels of reliability (Re = .90, Av = .90, Th = .86, AD = .92, NSC = .96, 
and DR = .90), as did the 6 PTSD (.96) and 16 DSO (.97) items. 
Discriminant validity analysis 
Hierarchical multiple regression analyses are presented in Table 4. The 
sociodemographic variables entered at Step 1 significantly contributed to the explanation of 
three of the six criterion variables, and the most robust predictor of each outcome was 
unemployment status. The introduction of the PTSD and DSO variables at Step 2 
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significantly increased the proportion of variance explained in every criterion variable. The 
largest effect was for negative trauma-related beliefs about the self (ΔR2 = .49; F(2, 133) = 
102.94, p < .001), followed by symptoms of GAD (ΔR2 = .43; F(2, 149) = 63.04, p < .001), 
depression (ΔR2 = .42; F(2, 148) = 75.21, p < .001), negative trauma-related beliefs about the 
world (ΔR2 = .34; F(2, 149) = 50.28, p < .001), panic disorder (ΔR2 = .22; F(2, 149) = 22.05, 
p < .001), and distress tolerance (ΔR2 = .20; F(2, 149) = 20.33, p < .001). 
 PTSD uniquely predicted PD symptoms (β = .40 (95% CI = .20, .59), p < .001), and 
was the strongest predictor of GAD symptoms (β = .42 (95% CI = .25, .58), p < .001). DSO 
significantly predicted negative trauma-related beliefs about the self (β = .70 (95% CI = .56, 
.84), p < .001), depression (β = .61 (95% CI = .46, .76), p < .001), negative trauma-related 
beliefs about the world (β = .53 (95% CI = .36, .70), p < .001), distress tolerance (β = -.52 
(95% CI = -.72, -.32), p < .001), and GAD symptoms (β = .35 (95% CI = .18, .51), p < .001). 
TABLE 4  
Discussion 
Consistent with previous findings (2-4), the prevalence of the proposed PTSD and 
CPTSD diagnoses combined were significantly lower than DSM-5 PTSD. Current and past 
findings suggest that the revised model of psychotraumatology outlined for ICD-11 provides 
a stricter criterion for diagnosis than that provided by the DSM-5. While the two systems 
demonstrated a reasonably high level of agreement regarding who should receive a diagnosis, 
there was a meaningful subset of individuals who qualified for a diagnosis of PTSD under 
DSM-5 but did not qualify for a diagnosis of PTSD or CPTSD under ICD-11. In contrast, 
only one person qualified for a diagnosis of PTSD or CPTSD under ICD-11, but did not 
qualify for a diagnosis of PTSD under DSM-5.  
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When the non-specific Re3 symptom was introduced, the combined ICD-11 PTSD 
and CPTSD diagnostic rate was no longer significantly different from DSM-5. Previous 
studies using secondary data sources have also found that differences in diagnostic rates 
between the two manuals are attributable to fewer individuals meeting the ICD-11’s Re 
requirements, and that if at least one non-specific re-experiencing symptom is introduced 
(e.g., upset upon reminders of the trauma, or, intrusive memories of the trauma), differences 
in diagnostic rates become non-significant (35). The conceptualisation of Re in ICD-11 is 
unique in that it focuses on the experience of reliving the traumatic event again in the here 
and now. This emphasis is based on evidence demonstrating that intrusive recollections of 
traumatic life events are common across psychiatric disorders (36); and that re-experiencing 
in the here and now distinguishes intrusive cognitive processes in PTSD from those observed 
in other disorders (37).  
The inclusion of a third, non-specific Re symptom is currently under consideration for 
those who do not possess a clear memory of their index trauma. Only 2 of 20 individuals who 
indicated no clear memory of their index trauma lost a diagnosis if this item was excluded; 
one lost a diagnosis of PTSD, and one lost a diagnosis of CPTSD. Current results suggest that 
the introduction of a third Re symptom may not be necessary to capture those without a clear 
memory of their index trauma, however further research with larger and more diverse trauma 
samples is necessary to determine the necessity of this third Re symptom.    
The CFA findings indicated that the latent structure of the ITQ was best represented 
by a two-factor second-order model that reflects the ICD-11’s distinction between PTSD and 
DSO symptomatology. This result replicates the only other assessment of the latent structure 
of the ITQ (11), and is consistent with findings derived from archival data (6-9). The CFA 
findings partially support the study’s second hypothesis: Models 2 and 4, which discriminate 
between PTSD and DSO symptoms at the first- and second-order level, respectively, 
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evidenced acceptable model fit. However, Model 3 which posits a single higher-order 
CPTSD factor, also evidenced acceptable fit. The generally good fit of Model 2 suggests that 
while the two-factor second-order model is plausible, and desirable due to its increased 
parsimony, it is not the only viable factorial solution of the ITQ that captures the distinction 
between PTSD and DSO symptoms. With respect to Model 3, given that most the sample met 
diagnostic status for CPTSD (53.6%) rather than PTSD (10.9%), it is unsurprising that this 
model offered reasonable fit. It is probable that future studies utilizing clinical samples 
characterised by high levels of CPTSD will find acceptable fit for this conceptualisation. 
Nonetheless, it was notable that Model 4, which distinguishes between the second-order 
factors of PTSD and DSO was deemed to be the most satisfactory representation of the latent 
structure of the ITQ, despite the strong correlation between these factors. The CFA results 
therefore support a distinction between PTSD and DSO symptomatology among this clinical 
sample.  
The validity of this distinction between PTSD and DSO was further evidenced by the 
results of the hierarchical multiple regression analyses. Consistent with the study’s third 
hypothesis, PTSD symptoms, but not DSO symptoms, positively predicted levels of PD; 
whereas DSO symptoms, but not PTSD symptoms, positively predicted symptoms of 
depression, and negative cognitions about the self and the world, and negatively predicted 
distress tolerance scores. PTSD and DSO were both significant, positive predictors of GAD 
symptoms, but PTSD was a stronger predictor than DSO. While the existing literature has 
indicated that CPTSD can be meaningfully distinguished from PTSD due to exposure to 
childhood traumatization (12), chronic traumatization (38), increased psychological distress 
(13), and female sex (39), the current findings demonstrate that PTSD and DSO possess 
differentially associated with multiple, clinically-relevant criterion variables. These 
differential associations, the robust magnitude of the effects, and the substantial variance 
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explained in each criterion variable, provides substantial empirical support for the 
discriminant validity of ICD-11 PTSD and CPTSD. 
The current study contains several limitations. First, although the sample was typical 
of secondary and tertiary care clinical groups, the small sample size and clinical nature of the 
sample limits generalizability to the wider trauma population. Replication using larger 
clinical, and community, samples is needed. Second, given that ICD-11 is still under 
development and not scheduled for publication until 2018, the ITQ will undergo revisions in 
the near future. These revisions will focus on streamlining the current set of indicators by 
which to correspond to the ICD-11 diagnostic guidelines. One of the major organising 
principles of the ICD-11 is to use as small a number of symptom indicators as possible so as 
to improve clinical utility (1), therefore an immediate challenge will centre on reducing the 
current list of DSO symptoms. While current results support the validity and reliability of the 
ITQ, considerable work will be required to finalise the scale and establish its psychometric 
properties. Third, although the current study represents the first instance in which DSM-5 and 
ICD-11 PTSD/CPTSD diagnostic rates have been compared using diagnostic-specific 
measures, it will be important to replicate the current study using clinician-administered 
diagnostic scales. Additionally, the current study did not include a measure of functional 
impairment for DSM-5 and ICD-11 meaning that estimated prevalence rates may be 
overestimated.  
The current study supports the factorial and discriminant validity of ICD-11 PTSD 
and CPTSD, and provides empirical support for the reliability and validity of the newly 
developed ITQ (10). These findings support the distinction between PTSD and DSO 
symptoms, and reveal that these constructs possess unique relationships with clinically-
relevant outcomes. The continued empirical support for ICD-11 CPTSD should encourage 
clinicians to screen for DSO symptomatology, and emphasizes the need for treatment 
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interventions that are specifically tailored to address these symptoms (40). Concerns have 
been expressed about the availability of two diagnostic systems that produce discrepant 
diagnostic rates, particularly for patients and carers as it is possible that one system may be 
used over another for the purposes of litigation, insurance coverage, and benefit refusal (41). 
Although these potentially negative consequences are issues that we believe clinicians and 
researchers should be acutely aware of, they may unfortunately be unavoidable consequences 
of our continuing search for the most accurate understanding of trauma-related 
psychopathology. 
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Table 1. Frequencies of symptom endorsement for each PTSD and DSO item of the ITQ, and 
symptom-based diagnostic estimates. 
 Valid % (n) Valid % (n) 
 PTSD Dx CPTSD Dx 
 10.9 (18) 53.6 (89) 
PTSD Symptom Endorsement   
Upsetting dreams (Re1) 72.7 (13) 92.1 (82) 
Reliving the event in the here and now (Re2) 77.8 (14) 93.3 (83) 
Upset upon reminders (Re3)* 100 (18) 95.5 (85) 
Internal avoidance (Av1) 94.4 (17) 100 (89) 
External avoidance (Av2) 100 (18) 93.3 (83) 
Being on guard (Th1) 88.9 (16) 97.8 (87) 
Jumpy/startled (Th2) 72.2 (13) 92.1 (82) 
DSO Symptom Endorsement   
Intense reactions (AD1) 72.2 (13) 88.8 (79) 
Long time to calm down (AD2) 72.2 (13) 95.5 (85) 
Feelings easily hurt (AD3) 55.6 (10) 92.0 (81) 
Uncontrollable anger (AD4) 33.3 (6) 58.4 (52) 
Reckless behaviour (AD5) 27.8 (5) 48.9 (43) 
Numb (AD6) 44.4 (8) 91.0 (81) 
Difficulty feeling pleasure (AD7) 27.8 (5) 86.4 (76) 
World is distant (AD8) 83.3 (15) 92.1 (82) 
Feeling outside of body (AD9) 61.1 (11) 69.3 (61) 
Failure (NSC1) 22.2 (4) 85.4 (76) 
Worthless (NSC2) 16.7 (3) 80.9 (72) 
Self-shame (NSC3) 33.3 (6) 88.8 (79) 
Guilt (NSC4) 33.3 (6) 95.5 (85) 
Cut-off from others (DR1) 44.4 (8) 96.6 (86) 
Difficult to stay close to others (DR2) 16.7 (3) 86.5 (77) 
Avoiding relationships (DR3) 16.7 (3) 73.0 (65) 
Note: Re = Re-Experiencing; Av = Avoidance; Th = Sense of Current Threat; AD = 
Affective Dysregulation; NSC = Negative Self Concept; DR = Disturbances in Relationships; 
DSO = Disturbances in Self-Organization; PTSD Dx = Probable ICD-11 Posttraumatic Stress 
Disorder diagnostic rates; CPTSD Dx = Probable ICD-11 Complex PTSD diagnostic rates; * 
Probable PTSD and CPTSD diagnostic rates are estimated without the inclusion of Re3. 
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Table 2. Model fit statistics for the alternative models of the ITQ. 
Models χ2 df P CFI TLI RMSEA (90% CI) BIC 
1 1135 209 .000 .871 .857 .161 (.152 - .170) 11652 
2 574 194 .000 .947 .937 .107 (.097 - .117) 11237 
3 554 203 .000 .951 .944 .101 (.091 - .111) 11212 
4 550 202 .000 .952 .945 .100 (.090 - .111) 11206 
5 659 205 .000 .937 .929 .114 (.104 - .124) 11325 
6 860 205 .000 .909 .897 .137 (.127 - .146) 11439 
7 947 208 .000 .897 .886 .144 (.135 - .154) 11558 
Note: Estimator = WLSMV; n = 171; χ2 = Chi-square Goodness of Fit statistic; df = degrees of freedom; P = Statistical significance; CFI = 
Comparative Fit Index; TLI = Tucker Lewis Index; RMSEA (90% CI) = Root-Mean-Square Error of Approximation with 90% confidence 
intervals; BIC = Bayesian Information Criterion; Best fitting model in bold. 
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Table 3. Standardized factor loadings (standard errors) for Model 4. 
Items Re Av Th AD NSC DR 
Upsetting dreams (Re1) .83 (.04)      
Reliving the event in the here and now (Re2) .92 (.03)      
Internal avoidance (Av1)  .93 (.03)     
External avoidance (Av2)  .89 (.04)     
Being on guard (Th1)   .88 (.04)    
Jumpy/Startled (Th2)   .85 (.04)    
Intense reactions (AD1)    .71 (.04)   
Long time to calm down (AD2)    .75 (.04)   
Feelings easily hurt (AD3)    .64 (.05)   
Uncontrollable anger (AD4)    .51 (.06)   
Reckless behaviour (AD5)    .56 (.06)   
Numb (AD6)    .85 (.03)   
Difficulty feeling pleasure (AD7)    .83 (.03)   
World is distant (AD8)    .80 (.03)   
Feeling outside of body (AD9)    .72 (.04)   
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Failure (NSC1)     .95 (.01)  
Worthless (NSC2)     .97 (.01)  
Self-shame (NSC3)     .90 (.02)  
Guilt (NSC4)     .86 (.03)  
Cut-off from others (DR1)      .96 (.03) 
Difficult to stay close to others (DR2)      .82 (.04) 
Avoiding relationships (DR3)      .79 (.04) 
Second-order factor loadings   PTSD  DSO  
Re-experiencing (Re)   .81 (.04)    
Avoidance (Av)   .71 (.04)    
Sense of current threat (Th)   .83 (.05)    
Affective dysregulation (AD)     1.00 (.02)*  
Negative self-concept (NSC)     .74 (.04)  
Disturbances in relationships (DR)     .86 (.03)  
Note: All factor loadings are statistically significant (p < .001); * Error variance was 0 indicating perfect reliability; Re = Re-experiencing in the 
here and now; Av = Avoidance; Th = Sense of current threat; AD = Affective dysregulation; NSC = Negative self-concept; DR = Disturbed 
relationships. 
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Table 4. Standardized beta values derived from the hierarchical regression model. 
 
Panic GAD Depression PTCI - Self PTCI - World Distress Tolerance 
Step 1 R2 .04 .06 .16*** .20*** .15*** .05 
Gender .05 -.02 .00 .03 -.01 -.11 
Age -.11 .04 .06 -.11 -.14 .10 
Unemployment status .17* .18* .32*** .36*** .33*** -.10 
Relationship Status .05 .11 .16* .20* .14 -.11 
Step 2 R2 Change .22*** .43*** .42*** .49*** .34*** .20*** 
Gender .03 -.05 -.02 .01 -.03 -.10 
Age -.08 .08 .09 -.08 -.11 .08 
Unemployment status .05 -.02 .11 .13* .14* .04 
Relationship status -.05 -.03 .03 .07 .03 -.04 
PTSD .40*** .42*** .13 .08 .13 .06 
DSO .14 .35*** .61*** .70*** .53*** -.52*** 
Total Variance Explained 26.1%*** 49.0%*** 58.3%*** 68.4%*** 49.3%*** 25.4%*** 
Note. DSO = Disturbances in Self-Organization; PTSD = Posttraumatic Stress Disorder; GAD = Generalized anxiety disorder; PTCI – Self = 
Negative cognitions of the self-subscale from the Posttraumatic Cognitions Inventory; PTCI – World = Negative cognitions about the world-
subscale from the Posttraumatic Cognitions Inventory * p < .05, ** p < .01, *** p < .001. 
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Figure 1. Alternative models of the latent structure of Complex PTSD symptoms. 
 
 
 
 
 
 
 
 
 
 
 
RUNNING TITLE: Validity of ICD-11 PTSD and CPTSD 
 30 
 
